Clinical Trials List
2018-07-30 - 2020-09-30
Phase III
Recruiting6
Terminated2
ICD-10C16.0
Malignant neoplasm of cardia
ICD-10C16
Malignant neoplasm of stomach
ICD-9151.0
Malignant neoplasm of cardia of stomach
-
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/15
Investigators and Locations
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Shao-Jung Hsu Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Rheun-Chuan Lee Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Chung-Pin Li Division of Hematology & Oncology
- Yun-Cheng Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
3 Recruiting
Audit
None
Co-Principal Investigator
- 劉建廷 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 賴香蘭 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 歐信佑 Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- 饒坤銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hui-Jen Tsai Division of General Internal Medicine
- Chia-Jui Yen Division of General Internal Medicine
- Yan-Shen Shan Division of General Internal Medicine
- Shang-Hung Chen Division of General Internal Medicine
- Nai-Jung Chiang Division of General Internal Medicine
- Kwang-Yu Chang Division of General Internal Medicine
- 姜乃榕 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
Audit
None
Taiwan National PI
Co-Principal Investigator
- Tsai-Sheng Yang Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- Mengting Peng Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- Wen-Chi Chou Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
7 Recruiting
Audit
None
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
43 participants
-
Global
550 participants
